One of the most convincing evidence of the anti-tumor activity of AMH is its additive effect on ovarian serous cancer with paclitaxel and cisplatin and its synergistic effect with rapamycin and doxorubicin (28) (Figure 6). The gene discussed is AMH; the disease is neoplasm.